Zai Lab Ltd

Zai Lab Ltd is a biopharmaceutical company that is dedicated to discovering, developing, and commercializing innovative medicines for patients in China and beyond. With a focus on oncology, autoimmune, and infectious diseases, Zai Lab aims to bring transformative therapies to patients with unmet medical needs. The company has a diverse pipeline of clinical-stage assets and a growing portfolio of commercial products. Zai Lab has established partnerships with leading global biopharmaceutical companies and academic institutions to leverage their expertise and resources. The company is committed to advancing the development of innovative medicines through cutting-edge science, rigorous clinical trials, and a patient-centric approach. Headquartered in Shanghai, China, Zai Lab also has offices in the United States and Australia. Zai Lab is listed on the NASDAQ Global Market under the ticker symbol "ZLAB."